6-Month Outcomes of PEMF to Nucleotide Sources Revealing Cell Sensory Experience in Pain Relief, Stress Relief and Anti Ageing Restoration

NCT04461470 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2020-07-16

No results posted yet for this study

Summary

Background:

The hz Clinic registry is a programme made of five scheduled cohorts designed to include participants dealing with Immunity compromise, Pain, Ageing and Stress (general and pandemic anxieties) who are to be followed for 6 month to five years in their structured routine of pulsed electro resonance (PEMF) to determine their clinical outcome in the real world, contributing evidence for benchmarking fellow cohort participant variance.

Here we report baseline characteristics, PEMF transfer events and outcomes in participants in the UK. This study serves as a calibration proforma for downstream real world evidence observations of PEMF in the field.

Conditions

  • Pain
  • Stress
  • Ageing Signs
  • Immunity Compromise

Interventions

GENETIC

epigenetic longitudinal waves

force - inducing energies using electromagnetic field(s)

Sponsors & Collaborators

  • East London Electric Company

    collaborator UNKNOWN
  • PropDesk

    collaborator UNKNOWN
  • MedCity

    collaborator UNKNOWN
  • UCL Partners

    collaborator UNKNOWN
  • Imperial College London Partners

    collaborator UNKNOWN
  • Health Innovation Network

    collaborator UNKNOWN
  • hz Clinic

    lead INDUSTRY

Principal Investigators

  • Christopher L Davies · East London Electric Company

Eligibility

Min Age
16 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-08-29
Primary Completion
2020-02-12
Completion
2024-09-12

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04461470 on ClinicalTrials.gov